History of Prostate Cancer Linked to Increased Melanoma Risk

This article originally appeared here.
Share this content:
Personal History of Prostate Cancer Linked to Melanoma Risk
Personal History of Prostate Cancer Linked to Melanoma Risk

(HealthDay News) -- History of prostate cancer (PCa) is associated with an increased risk of melanoma, according to a study published online Nov. 4 in the Journal of Clinical Oncology.

Wen-Qing Li, Ph.D., from the National Institutes of Health in Rockville, Md., and colleagues conducted a prospective study to examine the correlation between PCa and the risk of melanoma using data from 42,372 participants in the Health Professionals' Follow-Up Study (HPFS). Pathology reports were used to confirm biennially self-reported PCa and melanoma. The association was confirmed in 18,603 participants from the Physicians' Health Study (PHS).

The researchers identified 529 melanomas in the HPFS. The risk of melanoma was significantly increased with personal history of PCa (multivariate adjusted hazard ratio, 1.83; 95% confidence interval, 1.32 to 2.54), while the risk of non-melanoma skin cancer was marginally increased with PCa (hazard ratio, 1.08; 95% confidence interval, 0.995 to 1.16).

There was a significant difference in the magnitude of the association between melanoma and non-melanoma skin cancer. The risk of melanoma was not associated with personal history of other cancers. In the PHS, the association between PCa and risk of incident melanoma was confirmed (hazard ratio, 2.17).

"Our finding of PCa diagnosis as a risk predictor for melanoma holds general public health significance, which may inform clinical practice to address the queries and aid the care of patients with PCa," the authors write.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs